p53 and metabolism
暂无分享,去创建一个
[1] T. Russo,et al. p53 Suppresses the Nrf2-dependent Transcription of Antioxidant Response Genes* , 2006, Journal of Biological Chemistry.
[2] J. Richter,et al. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. , 2008, Genes & development.
[3] A. Giaccia,et al. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. , 1999, Cancer research.
[4] David Beach,et al. Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.
[5] J. Rathmell,et al. Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation* , 2008, Journal of Biological Chemistry.
[6] L. Donehower,et al. p53 in embryonic development: maintaining a fine balance , 1999, Cellular and Molecular Life Sciences CMLS.
[7] Yanping Zhang,et al. Putting a Finger on Growth Surveillance: Insight into MDM2 Zinc Finger-Ribosomal Protein Interactions , 2007, Cell cycle.
[8] Y. Pan,et al. p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment , 2004, Oncogene.
[9] Christopher Y. Park,et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects , 2008, Nature Genetics.
[10] L. Strong,et al. Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome , 2004, Cell.
[11] Masayuki Orimo,et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance , 2009, Nature Medicine.
[12] L. Neckers,et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1α , 1998, Nature.
[13] Jennifer E. Van Eyk,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2016 .
[14] D. Hardie,et al. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.
[15] Keshav K. Singh,et al. p53 regulates mtDNA copy number and mitocheckpoint pathway , 2009, Journal of carcinogenesis.
[16] R. Deberardinis,et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.
[17] Marie-Pier Champagne,et al. The Polycomb Group Gene Bmi1 Regulates Antioxidant Defenses in Neurons by Repressing p53 Pro-Oxidant Activity , 2009, The Journal of Neuroscience.
[18] J. Varley. Germline TP 53 Mutations and Li-Fraumeni Syndrome , 2003 .
[19] Y. Kinoshita,et al. The role of p53 in neuronal cell death , 2000, Cell Death and Differentiation.
[20] Craig B. Thompson,et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes , 2004, Nature Cell Biology.
[21] K. Meletis,et al. p 53 suppresses the self-renewal of adult neural stem cells , 2005 .
[22] A. Levine,et al. The coordinate regulation of the p53 and mTOR pathways in cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] Robin Mathew,et al. Role of autophagy in cancer , 2007, Nature Reviews Cancer.
[24] D. Klionsky,et al. Autophagosome formation: core machinery and adaptations , 2007, Nature Cell Biology.
[25] Eyal Gottlieb,et al. Metabolic transformation in cancer. , 2009, Carcinogenesis.
[26] K. Chien,et al. p 53 Is a Transcriptional Activator of the Muscle-specific Phosphoglycerate Mutase Gene and Contributes in Vivo to the Control of Its Cardiac Expression 1 , 2000 .
[27] O. Warburg. On the origin of cancer cells. , 1956, Science.
[28] P. Leder,et al. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.
[29] T. Jacks,et al. Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.
[30] Jian Yu,et al. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. , 2005, Cancer research.
[31] G. Shadel,et al. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. , 2009, Biochimica et biophysica acta.
[32] Joseph R. Milner,et al. An ATP/ADP-Dependent Molecular Switch Regulates the Stability of p53-DNA Complexes , 1999, Molecular and Cellular Biology.
[33] Simon Tavaré,et al. Autophagy mediates the mitotic senescence transition. , 2009, Genes & development.
[34] Arnold J. Levine,et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[36] Manuel Serrano,et al. The Arf/p53 pathway in cancer and aging. , 2008, Cancer research.
[37] Y. Liu,et al. p53 regulates hematopoietic stem cell quiescence. , 2009, Cell stem cell.
[38] Todd D. Westergard,et al. The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage , 2009, Proceedings of the National Academy of Sciences.
[39] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[40] Earl F. Glynn,et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function , 2008, Nature Medicine.
[41] S. Minucci,et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis , 2002, Oncogene.
[42] A. Rivera,et al. The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway* , 2005, Journal of Biological Chemistry.
[43] E. May,et al. Reciprocal down-regulation of p53 and SOD2 gene expression–implication in p53 mediated apoptosis , 2001, Oncogene.
[44] K. Ryan,et al. p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death , 2007, Cell Death and Differentiation.
[45] Ajjai Alva,et al. Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8 , 2004, Science.
[46] R. Deberardinis,et al. Autophagy in metazoans: cell survival in the land of plenty , 2005, Nature Reviews Molecular Cell Biology.
[47] L. Mayo,et al. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. , 2002, Trends in biochemical sciences.
[48] A. Gudkov,et al. Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors. , 2001, Biochemical pharmacology.
[49] Sam W. Lee,et al. Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions , 2003, Molecular and Cellular Biology.
[50] K. Vousden,et al. Coping with stress: multiple ways to activate p53 , 2007, Oncogene.
[51] S. Anderson,et al. Sugar and fat – that's where it's at: metabolic changes in tumors , 2008, Breast Cancer Research.
[52] M. Armoni,et al. The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression , 2004, Cancer Research.
[53] G. Atwal,et al. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans , 2009, Proceedings of the National Academy of Sciences.
[54] Y. Nakamura,et al. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. , 1999, Oncology research.
[55] A. Levine,et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. , 2007, Cancer research.
[56] Jacqueline Lehmann,et al. TP53 Status and Response to Chemotherapy in Breast Cancer , 2008, Pathobiology.
[57] Nektarios Tavernarakis,et al. Regulation of autophagy by cytoplasmic p53 , 2008, Nature Cell Biology.
[58] E. Morselli,et al. Stimulation of autophagy by the p53 target gene Sestrin2 , 2009, Cell cycle.
[59] H. Scrable,et al. Antagonistic pleiotropy and p53 , 2009, Mechanisms of Ageing and Development.
[60] C. Prives,et al. Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.
[61] B. Zhivotovsky,et al. The Warburg Effect returns to the cancer stage. , 2009, Seminars in cancer biology.
[62] Kevin Bray,et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. , 2006, Cancer cell.
[63] T. D. Schneider,et al. Discovery of novel tumor suppressor p53 response elements using information theory , 2008, Nucleic acids research.
[64] C. Thompson,et al. Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.
[65] Yoichi Taya,et al. Cyclin-dependent Kinases Phosphorylate p73 at Threonine 86 in a Cell Cycle-dependent Manner and Negatively Regulate p73* , 2003, Journal of Biological Chemistry.
[66] Kevin Ryan,et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 , 1998, The EMBO journal.
[67] E. Morselli,et al. Control of autophagy by oncogenes and tumor suppressor genes , 2009, Cell Death and Differentiation.
[68] N. Tanaka,et al. Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification , 2009, Proceedings of the National Academy of Sciences.
[69] S. Snyder,et al. p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.
[70] P. Hainaut,et al. Redox signalling and transition metals in the control of the p53 pathway. , 2000, Biochemical pharmacology.
[71] Govind Bhagat,et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.
[72] A. Nakagawara,et al. Activation of AMP-activated Protein Kinase Induces p53-dependent Apoptotic Cell Death in Response to Energetic Stress* , 2008, Journal of Biological Chemistry.
[73] A. Levine,et al. The tumor suppressor p53: Cancer and aging , 2008, Cell cycle.
[74] M. Armoni,et al. The Tumor Suppressor p 53 Down-Regulates Glucose Transporters GLUT 1 and GLUT 4 Gene Expression , 2004 .
[75] O. Feron,et al. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[76] Daniel J Klionsky,et al. Development by self-digestion: molecular mechanisms and biological functions of autophagy. , 2004, Developmental cell.
[77] N. Denko,et al. Hypoxia, HIF1 and glucose metabolism in the solid tumour , 2008, Nature Reviews Cancer.
[78] W. Ludwig,et al. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. , 2005, Blood.
[79] A. Carrier,et al. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. , 2009, Cancer research.
[80] K. Meletis,et al. p53 suppresses the self-renewal of adult neural stem cells , 2005, Development.
[81] A. Shakya,et al. Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity , 2009, Nature Cell Biology.
[82] M. Serrano,et al. The Arf / p 53 Pathway in Cancer and Aging , 2008 .
[83] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[84] Oksana Gavrilova,et al. p53 Regulates Mitochondrial Respiration , 2006, Science.
[85] J C Reed,et al. Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.
[86] M. Murphy,et al. ARF Induces Autophagy by Virtue of Interaction with Bcl-xl* , 2009, Journal of Biological Chemistry.
[87] Saroj P. Mathupala,et al. Glucose Catabolism in Cancer Cells , 2001, The Journal of Biological Chemistry.
[88] C. López-Otín,et al. Tissue-specific Autophagy Alterations and Increased Tumorigenesis in Mice Deficient in Atg4C/Autophagin-3* , 2007, Journal of Biological Chemistry.
[89] Yusuke Nakamura,et al. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses , 2004, Journal of Human Genetics.
[90] Yusuke Nakamura,et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion , 2007, Nature Genetics.
[91] B. Thiers. Central Role of p53 in the Suntan Response and Pathologic Hyperpigmentation , 2008 .
[92] Yiling Lu,et al. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.
[93] E. Cho,et al. A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress , 2009, Cell Death and Differentiation.
[94] A. Giaccia,et al. Advances in Brief Hypoxia Induces p 53 Accumulation through MDM 2 Down-Regulation and Inhibition of E 6-mediated Degradation 1 , 1999 .
[95] Peitan Liu,et al. PIFITHRIN-&agr; ATTENUATES P53-MEDIATED APOPTOSIS AND IMPROVES CARDIAC FUNCTION IN RESPONSE TO MYOCARDIAL ISCHEMIA/REPERFUSION IN AGED RATS , 2006, Shock.
[96] E. Morselli,et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy , 2008, Cell cycle.
[97] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[98] T. Mak,et al. Regulation of PTEN transcription by p53. , 2001, Molecular cell.
[99] A. Giaccia,et al. Hypoxia Links ATR and p53 through Replication Arrest , 2002, Molecular and Cellular Biology.
[100] P. Dagher. Apoptosis in ischemic renal injury: roles of GTP depletion and p53. , 2004, Kidney international.
[101] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[102] Sébastien Bonnet,et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. , 2007, Cancer cell.
[103] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[104] S. Bonhoeffer,et al. Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.
[105] A. Levine,et al. p53 regulates maternal reproduction through LIF , 2007, Nature.
[106] N. Sonenberg,et al. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53 , 2007, The EMBO journal.
[107] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[108] S. Berger,et al. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation. , 2006, Cancer research.
[109] M. Swaroop,et al. Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53* , 1999, The Journal of Biological Chemistry.
[110] Nobuyuki Tanaka,et al. p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation , 2008, Nature Cell Biology.
[111] E. Baehrecke,et al. Growth Arrest and Autophagy Are Required for Salivary Gland Cell Degradation in Drosophila , 2007, Cell.
[112] Guido Kroemer,et al. Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.
[113] T. Jacks,et al. A subset of p53-deficient embryos exhibit exencephaly , 1995, Nature Genetics.
[114] J. Stockman. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function , 2009 .
[115] Chi V. Dang,et al. The interplay between MYC and HIF in cancer , 2008, Nature Reviews Cancer.
[116] Ru Wei,et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.
[117] J. Varley. Germline TP53 mutations and Li‐Fraumeni syndrome , 2003, Human mutation.
[118] B. Viollet,et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. , 2007, Cancer research.
[119] P. Chumakov,et al. The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.
[120] Laura A. Solt,et al. The PP2A-Associated Protein α4 Is an Essential Inhibitor of Apoptosis , 2004, Science.
[121] N. Hay,et al. Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.
[122] Kevin M. Ryan,et al. DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis , 2006, Cell.
[123] Saroj P. Mathupala,et al. Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria , 2006, Oncogene.
[124] S. Piccolo. p53 Regulation Orchestrates the TGF-β Response , 2008, Cell.
[125] M.-H. Lee,et al. Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer , 2008, Cellular and Molecular Life Sciences.
[126] L. Montanaro,et al. Nucleolus, ribosomes, and cancer. , 2008, The American journal of pathology.
[127] J. D. Weber,et al. The ARF/p53 pathway. , 2000, Current opinion in genetics & development.
[128] Saroj P. Mathupala,et al. Glucose Catabolism in Cancer Cells , 1997, The Journal of Biological Chemistry.
[129] W. Gu,et al. p53-Dependent and p53-independent activation of autophagy by ARF. , 2008, Cancer research.
[130] K. Vousden,et al. PUMA and Bax-induced Autophagy Contributes to Apoptosis , 2009, Cell Death and Differentiation.
[131] E. Koonin,et al. Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.
[132] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[133] Edward J Merino,et al. A role for DNA-mediated charge transport in regulating p53: Oxidation of the DNA-bound protein from a distance , 2007, Proceedings of the National Academy of Sciences.
[134] Russell G. Jones,et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.
[135] Leah E. Mechanic,et al. p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis , 2004, Cancer Research.
[136] O. Bandmann,et al. p53‐dependent neuronal cell death in a DJ‐1‐deficient zebrafish model of Parkinson's disease , 2006, Journal of neurochemistry.
[137] Han You,et al. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. , 2006, Genes & development.
[138] C. Culmsee,et al. Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders. , 2006, Current Alzheimer research.
[139] Karen H. Vousden,et al. p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.
[140] K. Schulze-Osthoff,et al. The dark side of a tumor suppressor: anti-apoptotic p53 , 2008, Cell Death and Differentiation.